TETamer Mohamed El-Raggal

Tamer Mohamed El-Raggal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tamer Mohamed El-Raggal has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Adel A. Abdel Fattah

    From Magrabi Eye Hospital (El-Raggal, Fattah) and Ain Shams University (El-Raggal), Cairo, Egypt

    1 shared publication
  • Hussein S. El-Markaby

    Ophthalmology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    1 shared publication
  • Thanaa H. Mohammed

    Ophthalmology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    1 shared publication
  • Thanaa Helmy Mohamed Elsayed

    Department of Ophthalmology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    1 shared publication

Latest Publications

  • ACUTE POSTERIOR MULTIFOCAL PLACOID PIGMENT EPITHELIOPATHY

    by Hussein S. El-Markaby, Thanaa H. Mohammed, Tamer M. MD El-Raggal

    Purpose: The aim of this study was to describe cases with severe acute posterior multifocal placoid pigment epitheliopathy treated with tumor necrosis factor (TNF) blocker [Remicade (infliximab)] as regards the improvement of visual acuity, contralateral affection, and prevention of recurrence. Methods: We analyzed patients with severe acute posterior multifocal placoid pigment epitheliopathy confirmed by fluorescein fundus angiography as regards the demographic data (age, sex) and the most relevant clinical findings such as, visual acuity, retinal condition, association with other systemic diseases, and response to TNF blocker. Results: Eight patients were included in this study, 5 (62.5%) of them had unilateral lesion and 3 (37.5%) had bilateral lesions. The mean age of the patients was 29.5 ± 8.5 years (range, 19 to 42 years). Of them, 3 (37.5%) were women and 5 (62.5%) were men. All patients received TNF blocker (Remicade) in 4 doses (infusion of 100 mg), 4 weeks apart. The mean follow-up period was 23.6 ± 9.9 months (range, 8−36 months). During this period, no recurrence occurred with control of the associated systemic disease. There was a statistically significant improvement of the visual acuity from 0.49 ± 0.36 to 0.69 ± 0.21 (P < 0.05). Among patients with unilateral lesion, three developed contralateral affection. Adverse effects from Remicade did not occur. Conclusion: The TNF blocker can be used in patients with severe acute posterior multifocal placoid pigment epitheliopathy with no recurrence rate. However, it does not prevent the contralateral affection. Another prospective study with a control group and longer follow-up time is needed to confirm these results and to evaluate the effect of TNF blocker on final visual acuity.


  • Effect of corneal collagen crosslinking on femtosecond laser channel creation for intrastromal corneal ring segment implantation in keratoconus

    by Tamer M. El-Raggal

    To evaluate the effect of collagen crosslinking (CXL) on femtosecond laser channel creation for intrastromal corneal ring segments (ICRS) in keratoconic eyes. Magrabi Eye Hospital, Cairo, Egypt. Comparative case series. Eyes with grade II or III keratoconus were treated by CXL. After 6 months, channel creation was performed using an IntraLase FS-60 femtosecond laser. The eyes were randomly divided into 3 groups. The default femtosecond machine power setting was 1.5 mJ in Group 1, 1.6 mJ in Group 2, and 1.7 mJ in Group 3. A control group included virgin noncrosslinked keratoconic eyes in which the default power setting was 1.5 mJ. The degree of difficulty of ICRS insertion was judged subjectively. The degree of postoperative corneal haze was recorded. Fifteen eyes of 11 patients had CXL. Each group, including the control, comprised 5 eyes. After CXL, intracorneal channel creation using the 1.5 mJ default femtosecond power setting was incomplete and mechanical dissection was required to complete the channel. When the power setting was increased to 1.6 mJ or 1.7 mJ, channel creation could be completed; however, this increased the corneal reaction (haze) postoperatively. The corneal haze resolved in all eyes within 6 weeks, and there were no further complications. Femtosecond laser channel creation can be performed after CXL; however, the laser power must be modified. Results show channel dissection and ICRS implantation should be performed before or concurrent with CXL. The author has no financial or proprietary interest in any material or method mentioned.


  • Sequential versus concurrent KERARINGS insertion and corneal collagen cross-linking for keratoconus

    by Tamer M El-Raggal

    Purpose To evaluate the safety and efficacy of combined intracorneal ring segments (KERARINGS) insertion and corneal collagen cross-linking (CXL) performed in one session or two sessions and to present the refractive outcomes. Setting Magrabi Eye Hospital, Cairo, Egypt. Methods This prospective comparative study included 16 eyes of 10 patients with progressive mild to moderate keratoconus that were randomly divided into two groups. Group 1 included nine eyes that underwent KERARINGS insertion followed by CXL 6 montsh later; group 2 included seven eyes that underwent the two procedures at the same day. In both groups channel creation was performed using the femtosecond laser (Intralase FS 60). Results There was statistically significant improvement in both groups' uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA), with significant reduction in refractive error and keratometric values (p0.05). However, group 2 revealed more statistically significant reduction of keratometric values on topographical examination (p=0.046). The stromal haze that developed in both groups was more marked and persistent in group 2 than in group 1. Conclusion Combined KERARINGS insertion and CXL can be performed safely in one or two sessions. However, the same-session procedure appears to be more effective regarding the improvement in the corneal shape.


  • Open Access

    Mitomycin-C needle bleb revision in congenital glaucoma

    by Tamer Mohamed El-Raggal, Thanaa Helmy Mohamed Elsayed

    Purpose and Settings: This study was designed to evaluate the efficacy and safety of mitomycin-C (MMC) augmented needling procedure in the management of failed bleb after trabeculectomy in congenital glaucoma. This study was carried out at Ain Shams University Hospital. Patients and Methods: A retrospective study was carried on 30 eyes of 25 patients with congenital glaucoma with bleb failure after trabeculectomy. The mean age of the subjects was 7.3 ± 3.4 years (range, 1-12 years). Under general anesthesia, needling procedure was performed with adjunctive use of a mixture of 0.1 mL of MMC (0.04 mg/mL) and 0.2 mL of lidocaine 1% injected subconjunctivally. Needling was performed with a 30-gauge needle to dissect the areas of subconjunctival fibrosis and re-establish aqueous outflow. Results: Follow-up ranged from 6 to 20 months (mean, 9.23 ± 5.25 months). One needling revision was performed in 22 eyes (73.3%) and eight eyes (26.7%) received two needle revisions. The mean intraocular pressure (IOP) decreased from 26.9 ± 2.85 mmHg (range, 21-34 mmHg) before surgery to 15.63 ± 3.15 mmHg (range, 10-24 mmHg) at last follow-up. Complications included significant subconjunctival hemorrhage in six eyes, intraoperative bleb leak in two eyes, choroidal detachment in one eye, and minimal hyphema in one eye. Conclusion: MMC needle bleb revision appears to be an effective method to revive failed filtration surgery after trabeculectomy in patients with congenital glaucoma. This technique is effective in reducing IOP with preservation of the remaining conjunctiva for further surgery.


  • Open Access

    Riboflavin-ultraviolet a corneal cross-linking for keratoconus

    by TamerM El-Raggal

    Eratometric (K) reading less than 54 D and minimal corneal thickness greater than 420 microns. The corneal epithelium was removed manually within the central 8.5 mm diameter area and the cornea was soaked with riboflavin eye drops (0.1% in 20% dextran τ-500) for 30 minutes followed by exposure to UVA radiation (365 nm, 3 mW/cm2) for 30 minutes. During the follow-up period, uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest refraction, slit lamp examination and topographic changes were recorded at the first week, first month, 3 and 6 months. Results: There was statistically significant improvement of UCVA from a preoperative mean of 0.11 ± 0.07 (range 0.05–0.3) to a postoperative mean of 0.15 ± 0.06 (range 0.1–0.3) (P < 0.05). None of the eyes lost lines of preoperative UCVA but 1 eye lost 1 line of preoperative BSCVA. The preoperative mean K of 49.97 ± 2.81 D (range 47.20–51.75) changed to 48.34 ± 2.64 D (range 45.75–50.40). This decrease in K readings was statistically significant (P < 0.05). All eyes developed minimal faint stromal haze that cleared in 14 eyes within 1 month. In only 1 eye, this resulted in a very faint corneal scar. Other sight threatening complications were not encountered in this series. Progression of the original disease was not seen in any of the treated eyes within 6 months of follow-up. Conclusion: Riboflavin-UVA corneal cross-linking is a safe and promising method for keratoconus. Larger studies with longer follow up are recommended....


  • Sequential Intacs and Verisyse phakic intraocular lens for refractive improvement in keratoconic eyes

    by Tamer M. El-Raggal, Adel A. Abdel Fattah

    To evaluate the safety, efficacy, and stability of sequential Intacs (Addition Technology, Inc.) insertion and Verisyse phakic intraocular lens (pIOL) (AMO) implantation in selected cases of keratoconus. Magrabi Eye Hospital, Cairo, Egypt. Prospective data were collected from 8 eyes of 6 keratoconus patients with contact lens intolerance, clear corneas, a maximum K-value less than 60.0 diopters (D), and minimum corneal thickness greater than 400 mum. Two 0.45 mm Intacs were inserted through a 1.8 mm radial incision created at 70% of the corneal depth opposite the cone apex. The 2 rings were pushed to meet and embrace the cone apex. Refraction 6 months after Intacs insertion showed residual myopia greater than 6.0 D and residual astigmatism not more than 2.0 D. Thus, a phakic Verisyse IOL was implanted horizontally in the anterior chamber through a 6.5 mm superior clear corneal incision, which was closed with 3, 10-0 nylon sutures after a peripheral iridectomy was created. The uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), refraction, and topographic profiles were taken 1 week and 1, 3, 6, 9, 12, 18, and 24 months after the second surgery. All eyes achieved UCVA of 20/40 or better. The final spherical error ranged from -1.75 to +1.00 D and the cylindrical error, from 1.25 to 2.50 D. No eye lost lines of preoperative BCVA. These results were relatively stable throughout the follow-up period. Sequential Intacs and a Verisyse pIOL implantation was safe, stable, and effective in selected cases of keratoconus. It is a reversible surgery that is less invasive than penetrating keratoplasty (PKP). It can avoid or postpone the need for PKP, although it is not an alternative.